Sintilimab, Rituximab and Lenalidomide (sR2) As First-Line Treatment in Elderly Patients with Diffuse Large B-Cell Lymphoma: A Single-Arm, Open-Label, Phase 2 Trial
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Xiaolei Wei, Xutao Guo, Qi Wei, Yongqiang Wei, Ru Feng
Institutions: Nanfang Hospital, Southern Medical University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405039384